Physician profile
James Davis
NPI 1871974279
$11,160.90
in general payments reported to CMS, 2019-2025
10 companies · $51.74 in 2025
The $51.74 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.95 · 2022: $11K · 2023: $225 · 2024: $191 · 2025: $51.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,000.00 | 2022 | |
| Biotronik INC. | $3,504.33 | 2022 | |
| Abbott Laboratories | $2,062.60 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $228.16 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $142.22 | 2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.45 | 2022 | |
| Novartis Pharmaceuticals Corporation | $64.07 | 2023-2025 | |
| Amgen INC. | $26.95 | 2021 | |
| Philips North America LLC | $18.48 | 2025 | Mcot |
| E.R. Squibb & Sons, L.L.C. | $14.64 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.